Angioimmunoblastic T-cell lymphoma: Difference between revisions
No edit summary |
No edit summary |
||
Line 35: | Line 35: | ||
==[[Angioimmunoblastic T-cell lymphoma screening|Screening]]== | ==[[Angioimmunoblastic T-cell lymphoma screening|Screening]]== | ||
==[[Angioimmunoblastic T-cell lymphoma natural history|Natural History, Complications and Prognosis]]== | ==[[Angioimmunoblastic T-cell lymphoma natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
Line 46: | Line 46: | ||
[[Angioimmunoblastic T-cell lymphoma case study one|Case #1]] | [[Angioimmunoblastic T-cell lymphoma case study one|Case #1]] | ||
{{Hematological malignancy histology}} | {{Hematological malignancy histology}} |
Revision as of 19:12, 18 September 2012
Angioimmunoblastic T-cell lymphoma | |
ICD-10 | C84.4 (ILDS C84.460) |
---|---|
ICD-O: | 9705/3 |
MeSH | D007119 |
Angioimmunoblastic T-cell lymphoma Microchapters |
Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Angioimmunoblastic T-cell lymphoma On the Web |
American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma |
Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma |
Risk calculators and risk factors for Angioimmunoblastic T-cell lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Synonyms and keywords: AILD-type (lymphogranulomatosis X) T-cell lymphoma; AILT; immunoblastic lymphadenopathy; Angioimmunoblastic lymphadenopathy with dysproteinemia.
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies